The application of recombinant growth factor technology has yielded valuable signatures for key immune signaling molecules: IL-1A, IL-1B, IL-2, and IL-3. These produced forms, meticulously manufactured in laboratory settings, offer advantages like increased purity and controlled potency, allowing researchers to study their individual and combined e